Pathway Financial Advisers, LLC Ark Genomic Revolution ETF (De Transaction History
Pathway Financial Advisers, LLC
- $335 Million
- Q3 2025
A detailed history of Pathway Financial Advisers, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Pathway Financial Advisers, LLC holds 351 shares of ARKG stock, worth $9,438. This represents 0.0% of its overall portfolio holdings.
Number of Shares
351Holding current value
$9,438% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ARKG
# of Institutions
298Shares Held
20.5MCall Options Held
2.53MPut Options Held
2.8M-
Jpmorgan Chase & CO New York, NY3.94MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio